Progesterone Receptor (PR) Luciferase Reporter Plasmid
Research
Online Inquiry

Progesterone Receptor (PR) Luciferase Reporter Plasmid

Cat.No: RESK-0346 Datasheet

Quantities:
- +
Product Details Related Products
Product Name Progesterone Receptor (PR) Luciferase Reporter Plasmid
Catalog No. RESK-0346
Description This luciferase reporter plasmid is designed for monitoring the transcriptional activity level of the progesterone receptor (PR/PGR). PGR mainly mediates the physiological actions of progesterone, a key factor in the endocrine system, immune system, menstrual regulation, tissue repair and regeneration, inflammatory response, angiogenesis, blastocyst implantation, and maintenance of pregnancy, and it plays a particularly important role in reproduction. The plasmid is an engineered mammalian eukaryotic expression vector carrying multiple PR binding sites inserted at its multiple cloning site, enabling highly sensitive detection of PR activation. Predicted binding sites for other transcription factors in the vector have been appropriately mutated to enhance binding specificity without altering the original function, and the reduced plasmid size facilitates transfection.
Intended Use Detection of progesterone receptor transcriptional activity in the cellular progesterone signaling pathway; drug research; phenotypic analysis of gene overexpression and RNAi.
Principle / Technology Firefly luciferase reporter gene under the control of tandem PR response elements; progesterone-bound PR drives luciferase expression, and the resulting luminescence signal is proportional to PR transcriptional activity.
Detection Method Bioluminescent luciferase reporter gene assay
Sample Type Cultured mammalian cells (e.g., human and mouse cell lines)
Specificity Predicted binding sites for transcription factors other than the target factor have been appropriately mutated in the vector backbone, increasing transcription factor binding specificity while preserving the original reporter function.
Storage Conditions Store at -20 °C.
Shelf Life 1 year
Package Specifications 1 ug
Product Form Liquid (plasmid DNA in solution)
Quality Control The full plasmid sequence is verified to be correct. Functional assay validation has not been performed; users may refer to relevant published literature.
Concentration Approximately 100 ng/uL
Shipping Conditions Shipped on ice packs under low-temperature conditions.
Compatibility For use in mammalian species only (e.g., human and mouse).
Can be co-transfected with a Renilla luciferase reporter plasmid (e.g., a TK promoter-driven Renilla luciferase plasmid) for dual-luciferase reporter assays.
Application Notes / Precautions Recommended for transient transfection; stable transfection is not recommended.
The 1 ug package is not intended for direct use in experiments; it is recommended to first transform the plasmid into competent cells such as DH5a and amplify it by bacterial culture and plasmid extraction.
Transfection requires no special handling beyond standard plasmid transfection; follow the instructions of the transfection reagent used.
A matched luciferase reporter plasmid negative control is recommended as the negative control; users should select an appropriate positive control based on relevant literature.
The full plasmid sequence and flanking restriction sites are proprietary; the transcription factor binding site sequence and plasmid sequencing primer sequences are provided in the product manual.
Vector backbone: PGL-6-TA; luciferase promoter: PTA; resistance gene promoter: SV40.
Recognition Site Multiple PR binding sites inserted at the multiple cloning site

For research use only, not for clinical use.

0
0

There is no product in your cart.